Stock Market News

Corcept Therapeutics stock soars after successful Phase 3 trial

Mar 31, 2025 - 13:32
 0
Corcept Therapeutics stock soars after successful Phase 3 trial
Read More

Tags:

Previous Article

FAA approves United Airlines' first Starlink-equipped aircraft

Next Article

DHL acquires CRYOPDP, enters strategic partnership with Cryoport

Related Posts

Spirit Aero posts Q4 preliminary results, revenue ahead...

Feb 10, 2025  0

Europe's STOXX 600 closes near record high; German elections in focus

Europe's STOXX 600 closes near record high; German elec...

Feb 21, 2025  0

Stadler reports sharp earnings drop as disasters delay CHF 350 mln in sales

Stadler reports sharp earnings drop as disasters delay ...

Mar 19, 2025  0